Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 May 2017 for Aralez Pharmaceuticals Inc..
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Francis Martin Thrasher: trading record in brief
Francis Martin Thrasher discloses dealings in 2 companies, chiefly Aralez Pharmaceuticals Inc. and Stellar Pharmaceuticals Inc. We count 4 filings; the first trade dates from 27 February 2013 and the latest from 11 May 2017.
Every open-market trade on record is a purchase: 1 purchase worth €383k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 1 option exercise.
Most recently, on 12 May 2017, the filings show a share grant in Aralez Pharmaceuticals Inc. The most recent open-market purchase was published on 4 March 2013, 4,982 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Francis Martin Thrasher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
7,500 shares0Common Shares, without par valueSEC:0001104659-17-032412:0
7,500 shares0Common Shares, without par valueSEC:0001104659-16-128431:0
4,365 shares@ US$2.82100.0% of flowCommon Shares, without par valueSEC:0001104659-16-127493:0
1,250,000 shares@ US$0.40Common SharesSEC:0001357211-13-000003:0
Canonical exit: 28 May 2013 (T+90)
4 of 4 declarations
